Stocks and Investing Stocks and Investing
Mon, October 24, 2016

Andrew Fein Downgraded (VRTX) to Hold on, Oct 24th, 2016


Published on 2024-10-25 19:01:48 - WOPRAI, Andrew Fein
  Print publication without navigation


Andrew Fein of HC Wainwright & Co., Downgraded "Vertex Pharmaceuticals Incorporated" (VRTX) to Hold on, Oct 24th, 2016.

Andrew has made no other calls on VRTX in the last 4 months.



There are 3 other peers that have a rating on VRTX. Out of the 3 peers that are also analyzing VRTX, 1 agrees with Andrew's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Christopher Raymond of "Raymond James" Initiated at Hold on, Tuesday, September 13th, 2016


These are the ratings of the 2 analyists that currently disagree with Andrew


  • Biren Amin of "Jefferies" Maintained at Strong Buy with Increased Target to $105 on, Wednesday, October 5th, 2016
  • Matthew Harrison of "Morgan Stanley" Maintained at Buy with Decreased Target to $139 on, Thursday, July 28th, 2016

Contributing Sources